Qutenza capsaicin regulatory update

FDA's Anesthetic and Analgesic Drug Products Advisory Committee will meet on Feb. 9 to discuss an sNDA from NeurogesX for a 30-minute application of Qutenza capsaicin to treat HIV-associated periphera...